Followers

September 19, 2023

60 Degrees Pharma withdraws mid-stage study application for COVID drug

The decision follows FDA's comments regarding the study design, the company said, adding that it plans to resubmit a revised application later in the year after a feasibility assessment.


No comments:

Post a Comment